New York State Common Retirement Fund Cabaletta Bio, Inc. Transaction History

New York State Common Retirement Fund

  • $74.6 Billion
  • Q4 2024

A detailed history of New York State Common Retirement Fund transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 990 shares of CABA stock, worth $2,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
990
Previous 990 -0.0%
Holding current value
$2,178
Previous $5,000 60.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$3.94 - $8.24 $319,809 - $668,840
-81,170 Reduced 98.8%
990 $5,000
Q2 2024

Jul 31, 2024
SELL
$7.22 - $18.82 $1,631 - $4,253
-226 Reduced 0.27%
82,160 $615,000
Q1 2024

May 07, 2024
BUY
$16.79 - $25.38 $960,304 - $1.45 Million
57,195 Added 227.05%
82,386 $1.41 Million
Q4 2023

Feb 01, 2024
BUY
$12.21 - $23.36 $181,049 - $346,382
14,828 Added 143.09%
25,191 $572,000
Q3 2023

Nov 07, 2023
BUY
$11.84 - $18.65 $4,297 - $6,769
363 Added 3.63%
10,363 $158,000
Q2 2023

Aug 07, 2023
BUY
$7.65 - $13.95 $76,500 - $139,500
10,000 New
10,000 $129,000
Q3 2021

Nov 02, 2021
SELL
$7.0 - $12.5 $714 - $1,275
-102 Closed
0 $0
Q2 2021

Aug 02, 2021
SELL
$7.2 - $11.73 $44,625 - $72,702
-6,198 Reduced 98.38%
102 $1,000
Q1 2021

May 11, 2021
SELL
$10.39 - $14.53 $71,691 - $100,257
-6,900 Reduced 52.27%
6,300 $70,000
Q2 2020

Aug 07, 2020
BUY
$6.39 - $11.28 $65,817 - $116,184
10,300 Added 355.17%
13,200 $147,000
Q1 2020

May 06, 2020
SELL
$6.0 - $18.67 $42,000 - $130,690
-7,000 Reduced 70.71%
2,900 $21,000
Q4 2019

Feb 05, 2020
BUY
$7.88 - $17.71 $78,012 - $175,329
9,900 New
9,900 $138,000

Others Institutions Holding CABA

# of Institutions
115
Shares Held
39.6M
Call Options Held
297K
Put Options Held
98.6K
View Full List

About Cabaletta Bio, Inc.

CABA Quotes by TradingView
  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $63.8M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email